Immix Biopharma (IMMX) Q3 2025 Earnings

8AugConfirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-0.24
-0.21
-0.18
-0.15

Details

Expected EPS
-0.16
Actual EPS
-0.22
Surprise EPS
-0.06
Surprise Percent
+37.5%

Description

Immix Biopharma (IMMX) has reported earnings of -0.22 per share for Q3 2025.

0 Comments

Share your thoughts